The present invention relates to the use of particular macrocycles that are inhibitors of the proteasomic degradation of p27, in particular argyrin and derivatives thereof, for a treatment in a variety of conditions, such as the induction of immunotolerance, autoimmune diseases, bacterial infections, and proliferative diseases, such as cancers.
本发明涉及使用特定的大环化合物,这些大环化合物是p27蛋白质降解的
蛋白酶体
抑制剂的
抑制剂,尤其是
精胺及其衍
生物,用于治疗多种病症,如诱导免疫耐受、自身免疫疾病、细菌感染以及增殖性疾病,如癌症。